1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. REGENERATIVE MEDICINE MARKET BY TECHNOLOGY
4.1. Introduction
4.2. Stem cell Therapy
4.3. Gene Therapy
4.4. Tissue Engineering
4.5. Others
5. REGENERATIVE MEDICINE MARKET BY APPLICATION
5.1. Introduction
5.2. Cardiovascular
5.3. Oncology
5.4. Dermatology
5.5. Orthopedics and Musculoskeletal
5.6. Wound Healing
5.7. Ophthalmology
5.8. Others
6. REGENERATIVE MEDICINE MARKET BY END-USER
6.1. Introduction
6.2. Hospitals and Clinics
6.3. Government
6.4. Academic Research Institutes
6.5. Others
7. REGENERATIVE MEDICINE MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. Israel
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. Japan
7.6.3. India
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Amgen Inc.
9.2. Biogen Inc.
9.3. Bristol-Myers Squibb Company
9.4. CRISPR Therapeutics AG
9.5. Editas Medicine, Inc.
9.6. Fate Therapeutics, Inc.
9.7. Gilead Sciences, Inc.
9.8. JCR Pharmaceuticals Co., Ltd.
9.9. MEDIPOST Co., Ltd.
9.10. Novartis AG
9.11. Orgenesis Inc.
9.12. Rege Nephro, Inc.
9.13. Regenexx
9.14. Sarepta Therapeutics, Inc.
9.15. Smith & Nephew plc
9.16. Takeda Pharmaceutical Company Limited
9.17. Vericel Corporation